Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
CertiRx will integrate its TraxSecur mark into IN2Trace's CureCloud serialisation software
Alpha blockers and 5-alpha reductase inhibitors can help alleviate the symptoms of benign prostatic hyperplasia, but their efficacy is not sustained and adverse effects are common
Protecting patients from product fraud and tampering has become a major industry and regulatory initiative. Justin Schroeder, Executive Director Marketing, Business Development and Design, PCI Pharma Services, summarises progress and highlights some unresolved issues
Midostaurin, is under development at Novartis for the treatment of acute myeloid leukaemia and other blood cancers
Six firms are winners, with three more receiving an Honourable Mention from the judging panel
Predictions of healthy growth in pharma outsourcing in 2015 seem to have been fulfilled, but can the trend be sustained this year? The latest surveys from Nice Insight suggest it can, writes Nigel Walker, Managing Director, That’s Nice LLC/Nice Insight
French biopharmaceutical firm selects pumps from Watson-Marlow Fluid Technology Group
Installing a successful vision inspection system requires expertise in many disciplines – mechanics, electronics, robotics, software, factory networks and CAD systems. Robert Pounder, Technical Director, Olmec UK looks at some recent projects
Led by treatments for HIV, respiratory illnesses and meningitis vaccines
Tristram Evans, Clinical Quality Director, PCI Pharma Services UK, looks at the impact of recent changes to the regulations governing Medicinal Products for Human Use and Clinical Trials in the EU
It will be based on the site occupied by the Royal Marsden Hospital and its academic partner, the Institute of Cancer Research (ICR) in Sutton, Surrey
It has long been known that pharmaceutical residues can become hormone-affecting ‘endocrine disrupters’ when released into the environment and future controls are likely – but how will the legislators tackle the issue? Manufacturing Chemist reports